123 results
Page 4 of 7
6-K
EX-1.1
abe7j3gcbe lz2vunrt
11 Feb 22
Current report (foreign)
5:29pm
424B5
zq67o3 pg
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.3
z1u7scjydsj
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
6-K
uh8g6zwx0m72ko6ok
16 Aug 21
Current report (foreign)
7:00am
6-K
x193rcenf9u7sgw dow
11 May 21
Current report (foreign)
7:00am
424B8
baq2x
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
fhvqewb4 jz
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-4.1
kzslu791
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
424B5
vei uro8n06u
12 Apr 21
Prospectus supplement for primary offering
9:07am
424B5
ptpy1wx
9 Apr 21
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
h9r967r8v5k0
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
424B5
fzqxvi7e
15 Jan 21
Prospectus supplement for primary offering
7:00am
F-3
s747o y73ms8
30 Dec 20
Shelf registration (foreign)
4:17pm
424B3
kbmx9 voosz
16 Nov 20
Prospectus supplement
7:15am
6-K
rao2z
16 Nov 20
Current report (foreign)
7:00am
424B3
56c0t
26 Aug 20
Prospectus supplement
5:21pm
6-K
5f94 4lw99on4d1p7n
13 Aug 20
Current report (foreign)
7:00am
S-8
EX-5.1
55dyg5p
5 Aug 20
Registration of securities for employees
4:31pm
6-K
fienlxrj4tpx94hql
14 May 20
Current report (foreign)
7:25am